Top

Published in:

01-03-2011 | Case Report

A rare trigger for macrophage activation syndrome

Authors: Shikhar Agarwal, Jayavani Moodley, Gati Ajani Goel, Karl S. Theil, Syed S. Mahmood, Richard S. Lang

Published in: Rheumatology International | Issue 3/2011

Abstract

Macrophage activation syndrome (MAS) is a disorder characterized by increased activation of mononuclear cells leading to phagocytosis of blood cell precursors in the bone marrow. We describe a case of MAS triggered by disseminated histoplasmosis occurring in a patient with Still’s disease on long-term treatment with adalimumab.

Kuzmanova SI (2005) The macrophage activation syndrome: a new entity, a potentially fatal complication of rheumatic disorders. Folia Med (Plovdiv) 47(1):21–25

Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14(5):548–552CrossRefPubMed

Rumbach L, Berger E, Tatu L et al (1997) Transient multiple cranial nerve involvement as a first sign of macrophage activation syndrome. J Neurol Neurosurg Psychiatry 62(3):292–293CrossRefPubMed

Lambotte O, Cacoub P, Costedoat N, Le Moel G, Amoura Z, Piette JC (2003) High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol 30(5):1027–1028PubMed

Sanchez A, Celaya AK, Victorio A (2007) Histoplasmosis-associated hemophagocytic syndrome: a case report. AIDS Read 17(10):496–499PubMed

Pinto L, Kagalwala F, Singh S, Balakrishnan C, Prabhu SV, Khodaiji S (2007) Macrophage activation syndrome: experience from a tertiary referral centre. J Assoc Physicians India 55:185–187PubMed

Title: A rare trigger for macrophage activation syndrome
Authors: Shikhar Agarwal
Jayavani Moodley
Gati Ajani Goel
Karl S. Theil
Syed S. Mahmood
Richard S. Lang
Publication date: 01-03-2011
Publisher: Springer-Verlag
Published in: Rheumatology International / Issue 3/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-009-1204-0

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A rare trigger for macrophage activation syndrome

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Diagnosis of a 65-year-old male patient with Takayasu’s arteritis by 18F-FDG PET/CT

Uveitis in celiac disease with an excellent response to gluten-free diet: third case described

Current, new and future treatments of osteoporosis

QT interval dispersion in North Indian children with Kawasaki disease without overt coronary artery abnormalities

Anti-TNF therapies: a comprehensive analysis of adverse effects associated with immunosuppression

Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page